jump to content jump to footer
Prof. Dr. Timm Denecke discusses AI-based early detection of liver cancer at RÖKO 2026

Predicting hepatocellular carcinoma (HCC) before it develops: Artificial Intelligence meets MRI

At RÖKO 2026, we spoke with Prof. Dr. Timm Denecke, Director of Radiology at Leipzig University Hospital, about RACOON-MARDER, a research project using artificial intelligence to detect the earliest imaging signs of hepatocellular carcinoma (HCC) in high-risk patients. By training AI on structured MRI data from across Germany's university hospitals, the project aims to identify which patients truly need intensive screening — and catch liver cancer before it becomes cancer. Mint Medical is proud to support this research as a technical network partner.

Read the full interview to find out how AI could reshape liver cancer screening.

Or watch the video interview with Prof. Denecke on Youtube. 

Lung Cancer Screening in Germany – A Turning Point for Early Detection
Few topics are currently as impactful in radiology as lung cancer screening. From 2026, Germany is expected to roll out a nationwide program, marking…
Read more
ESOI-EORTC Workshop 2025: A Recap of a Successful Event in Brussels
The annual ESOI-EORTC workshop, organized by the European Society of Oncological Imaging (ESOI) and the European Organization for Research and…
Read more
ESOI-EORTC Workshop: Hands-On Training in Assessing Tumor Response to Treatment
The ESOI-EORTC workshop, hosted by the European Society of Oncological Imaging (ESOI) and the European Organization for Research and Treatment of…
Read more
scroll-top